Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am Eastern Time.

Conference Call and Webcast Information

Event

Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call

Date

Thursday, August 15, 2024

Time

10:00am ET

Conference Call

1-877-877-1275 (U.S.)

1-412-858-5202 (international)

Webcast

https://event.choruscall.com/mediaframe/webcast.html?webcastid=bU2HFqrt

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com

SOURCE: Biofrontera Inc.

View the original press release on accesswire.com

Staff

Recent Posts

AmeriGuard Security Services, Inc. Awarded Prestigious Contract by U.S. Department of Veterans Affairs for Non-Emergency Medical Transportation Services for the Loma Linda Healthcare System

AmeriGuard Security Services, Inc. Transportation platform TransportUS, Inc., expands services with an additional new contract…

5 hours ago

IDEOlogy Health Ranks No. 717 on the 2024 Inc. 5000 Fastest-Growing Private Companies in America

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. revealed today that IDEOlogy Health is No. 717…

5 hours ago

Colorectal Cancer and Gut Health: Insights from Dr. Richard Birkett

BOSTON, MA / ACCESSWIRE / August 13, 2024 / Colorectal cancer, a serious condition affecting…

5 hours ago

Glow Lifetech Delivers 480% Quarter-Over-Quarter Revenue Growth with Industry-Leading 70% Gross Margin

Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC PINK:…

10 hours ago

ActivTrak Ranks No. 2335 on the 2024 Inc. 5000

With Three-Year Revenue Growth of 233 Percent, ActivTrak Ranks No. 2335 Among America's Fastest-Growing Private…

11 hours ago